Sign up
Pharma Capital

Andrew Kessel

Journalist

Andrew covers daily market movers, newsworthy cannabis stocks and other small-cap briefs. He previously worked as a fact-checker for both PolitiFact and Guideposts, covered higher education for the Columbia Missourian and interned at Rolling Stone Magazine. Andrew earned his Bachelor of Journalism from the University of Missouri in 2017. 

1551807154_andrew.jpg


© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.